e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
Pulmonary circulation: basic science
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of microRNA 17/92 cluster and microRNA 21 in the pathogenesis of pulmonary hypertension – Novel therapeutic targets
S. Pullamsetti, C. Doebele, A. Fischer, R. Savai, B. Kojonazarov, B. Dahal, H. Ghofrani, N. Weissmann, F. Grimminger, A. Bonauer, W. Seeger, A. Zeiher, S. Dimmeler, R. Schermuly (Bad Nauheim, Frankfurt, Giessen, Germany)
Source:
Annual Congress 2013 –Pulmonary circulation: basic science
Session:
Pulmonary circulation: basic science
Session type:
Poster Discussion
Number:
5160
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pullamsetti, C. Doebele, A. Fischer, R. Savai, B. Kojonazarov, B. Dahal, H. Ghofrani, N. Weissmann, F. Grimminger, A. Bonauer, W. Seeger, A. Zeiher, S. Dimmeler, R. Schermuly (Bad Nauheim, Frankfurt, Giessen, Germany). Role of microRNA 17/92 cluster and microRNA 21 in the pathogenesis of pulmonary hypertension – Novel therapeutic targets. Eur Respir J 2013; 42: Suppl. 57, 5160
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Eosinophils and airway nerves in asthma
Related content which might interest you:
Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
Role of survivin in experimental models of pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Expression and function of aquaporin 1 in hypoxia-induced pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
PSGR olfactory receptor: A new potential target in pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Functional characterization of BMPR2 gene in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Targeting aquaporin 1 reverses hypoxia-induced pulmonary hypertension in mice
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
A new molecular genetic diagnostic approach for pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Molecular characterization of the ACVRL1 and ENG genes in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Elucidating signalling pathways in pulmonary hypertension using a microRNA knockout mouse model – In vitro and in vivo data
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Role of the TrkA receptor in experimental severe pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
Analysis of BMPR2 gene expression in B-lymphocytes of pulmonary arterial hypertension patients
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
AAV-
Tgfb1
vs. bleomycin: Analysis of gene expression profiles in two models of pulmonary fibrosis
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014
Characterization of a new rat model of heritable PAH
Source: International Congress 2016 – Pulmonary hypertension: novel insights
Year: 2016
Detection and characterization of long noncoding RNAs in hypoxia-induced pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: novel insights
Year: 2016
microRNA profile in COPD patients with and without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Circulating microRNA signature and its novel involvement in pathogenesis of chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept